Welcome to the patient information website for PrCAMZYOSTM
(mavacamten capsules)
This material was developed by Bristol Myers Squibb as part of the risk minimization plan for CAMZYOS.
This material is not intended for promotional use.
CAMZYOS is a prescription-only heart medicine used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (also known as oHCM).
This website provides important safety information on CAMZYOS. Tell any healthcare professional who sees you that you are taking CAMZYOS. In addition to this website, you should have received a Patient Guide and Patient Card. The Patient Card contains information on the main risks of CAMZYOS and the contact details of your prescriber. For more information, please refer to the Patient Medication Information. If you have further questions, talk to your prescriber, doctor or pharmacist.